| Literature DB >> 19015637 |
E Gresko1, S Ritterhoff, J Sevilla-Perez, A Roscic, K Fröbius, I Kotevic, A Vichalkovski, D Hess, B A Hemmings, M L Schmitz.
Abstract
The promyelocytic leukemia (PML) tumor suppressor protein, a central regulator of cell proliferation and apoptosis, is frequently fused to the retinoic acid receptor-alpha (RARalpha) in acute PML. Here we show the interaction of PML with another tumor suppressor protein, the serine/threonine kinase homeodomain-interacting protein kinase (HIPK2). In response to DNA damage, HIPK2 phosphorylates PML at serines 8 and 38. Although HIPK2-mediated phosphorylation of PML occurs early during the DNA damage response, the oncogenic PML-RARalpha fusion protein is phosphorylated with significantly delayed kinetics. DNA damage or HIPK2 expression leads to the stabilization of PML and PML-RARalpha proteins. The N-terminal phosphorylation sites contribute to the DNA damage-induced PML SUMOylation and are required for the ability of PML to cooperate with HIPK2 for the induction of cell death.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19015637 DOI: 10.1038/onc.2008.420
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867